Literature DB >> 28956227

Various N-glycoforms differentially upregulate E-NTPDase activity of the NTPDase3/CD39L3 ecto-enzymatic domain.

Alexander H Zhong1, Z Gordon Jiang1, Richard D Cummings1,2, Simon C Robson3.   

Abstract

The GDA1/CD39 ecto-nucleoside triphosphate diphosphosphohydrolase (E-NTPDase) superfamily is a group of eight heavily glycosylated ecto-enzymes that hydrolyze extracellular nucleosides di- and tri-phosphates in the presence of divalent cations, to generate the monophosphate derivatives. This catalytic process differentially regulates a complex array of purinergic signaling responses. NTPDase3/CD39L3is dominantly expressed in pancreatic islet cells, where it may regulate insulin secretion, and has seven N-linked glycosylation sites with four close to five highly conserved domains called "apyrase conserved regions" (ACRs). In a manner similar to CD39, NTPDase3/CD39L3 uses ATP as its preferential substrate and also possesses significant activities toward other triphosphate and diphosphate nucleosides. To understand the mechanism of the ecto-NTPDase activity and substrate specificity, potentially impacted by N-glycans, we have generated soluble enzymatic domains of NTPDase3/CD39L3 in human embryotic kidney cells with four different glycan modifications. These include mannose5-9 glycans with kifunesine treatment, single GlcNAc-Asn by treatment with EndoH, de-glycosylated form by treatment with PNGaseF, and wild-type glycans. Our functional data indicate that the non-glycosylated NTPDase3/CD39L3 ecto-enzymatic domain retains activity, but that N-glycan attachments, such as the GlcNAc-Asn, substantially upregulate specific NTPDase activity by 2-20 fold. Both the Vmax and the Km on di- or tri-phosphate nucleosides are substantially and differentially altered by the glycan attachments. Structural modeling analysis based on putative structures derived from bacterial-originated CD39 domain proteins suggests that N-glycan modifications at Asn149 next to ACR2 and/or Asn454, N-terminal to ACR5 have critical roles in regulating the catalytic pocket of NTPDase3/CD39L3. Our data provide both new insights into the enzymatic mechanisms of NTPDase family members and further evidence that N-glycans directly modulate functional ectonucleotidase activities.

Entities:  

Keywords:  ATP; CD39; CD39L3; Glycosylation

Mesh:

Substances:

Year:  2017        PMID: 28956227      PMCID: PMC5714850          DOI: 10.1007/s11302-017-9587-y

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  36 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

2.  Dynamic motions of CD39 transmembrane domains regulate and are regulated by the enzymatic active site.

Authors:  Alison Grinthal; Guido Guidotti
Journal:  Biochemistry       Date:  2004-11-02       Impact factor: 3.162

3.  Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity.

Authors:  J Schulte am Esch; J Sévigny; E Kaczmarek; J B Siegel; M Imai; K Koziak; A R Beaudoin; S C Robson
Journal:  Biochemistry       Date:  1999-02-23       Impact factor: 3.162

4.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

5.  Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling.

Authors:  Matthias Zebisch; Norbert Sträter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

6.  Requirement of Cys399 for processing of the human ecto-ATPase (NTPDase2) and its implications for determination of the activities of splice variants of the enzyme.

Authors:  Jesús Mateo; Silvia Kreda; Christopher E Henry; T Kendall Harden; José L Boyer
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

7.  CD39 is an ecto-(Ca2+,Mg2+)-apyrase.

Authors:  T F Wang; G Guidotti
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

8.  Characterization of Rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies.

Authors:  Matthias Zebisch; Norbert Sträter
Journal:  Biochemistry       Date:  2007-10-02       Impact factor: 3.162

Review 9.  Roles of N-linked glycans in the endoplasmic reticulum.

Authors:  Ari Helenius; Markus Aebi
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

10.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

View more
  3 in total

1.  Functionalized Oxoindolin Hydrazine Carbothioamide Derivatives as Highly Potent Inhibitors of Nucleoside Triphosphate Diphosphohydrolases.

Authors:  Saira Afzal; Mariya Al-Rashida; Abdul Hameed; Julie Pelletier; Jean Sévigny; Jamshed Iqbal
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 2.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

3.  Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.

Authors:  Elizabeth H Zhong; Carola Ledderose; Paola De Andrade Mello; Keiichi Enjyoji; Justin Mark Lunderberg; Wolfgang Junger; Simon C Robson
Journal:  Am J Physiol Cell Physiol       Date:  2020-10-14       Impact factor: 5.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.